Los Angeles Capital Management’s Fulgent Genetics FLGT Stock Holding History

Los Angeles Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83K	Sell	178 -8,130	-98%	-$176K	﹤0.01%	2245
2025 Q4	$188K	Buy	+8,308	New	+$216K	﹤0.01%	1262
2022 Q4	–	Sell	-10,183	Closed	-$388K	–	1214
2022 Q3	$388K	Sell	10,183 -9,431	-48%	-$473K	﹤0.01%	994
2022 Q2	$1.07M	Buy	19,614 +8,388	+75%	+$461K	0.01%	698
2022 Q1	$701K	Buy	11,226 +2,827	+34%	+$186K	﹤0.01%	902
2021 Q4	$845K	Buy	8,399 +1,607	+24%	+$141K	﹤0.01%	783
2021 Q3	$611K	Hold	6,792	–	–	﹤0.01%	960
2021 Q2	$626K	Sell	6,792 -1,780	-21%	-$142K	﹤0.01%	1073
2021 Q1	$828K	Sell	8,572 -15,727	-65%	-$1.62M	﹤0.01%	984
2020 Q4	$1.27M	Buy	+24,299	New	+$1.02M	0.01%	831

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Los Angeles Capital Management's FLGT Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Fulgent Genetics (FLGT) stake by 98% in Q1 2026, selling an estimated $176K and leaving 178 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Los Angeles Capital Management first reported a position in FLGT in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.27M in Q4 2020. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

Los Angeles Capital Management held 178 shares of Fulgent Genetics worth $2.83K as of Q1 2026.
Los Angeles Capital Management sold 8,130 Fulgent Genetics shares in Q1 2026, an estimated $176K.
Fulgent Genetics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2245 holding.
Los Angeles Capital Management first reported a position in Fulgent Genetics in Q4 2020 and has held it in 10 quarters since.
Los Angeles Capital Management's Fulgent Genetics position peaked at $1.27M in Q4 2020.
157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.